The only botanical that targets 5-LOX instead of COX and nobody's marketing it that way

Curcumin, ginger, omega-3 they all target the COX pathway (same as ibuprofen). Boswellia (AKBA) is the only major botanical that selectively inhibits 5-lipoxygenase, a completely different inflammatory pathway producing leukotrienes, not prostaglandins. That's a unique mechanism shared with no other natural ingredient. Yet boswellia is marketed as "another joint ingredient" competing on the same shelf as curcumin. It should be positioned as the complementary mechanism.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23194864/https://pmc.ncbi.nlm.nih.gov/articles/PMC1909340/ https://pubmed.ncbi.nlm.nih.gov/7603462/